Publication: Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis
Issued Date
2007-12-01
Resource Type
ISSN
00221899
DOI
Other identifier(s)
2-s2.0-38449106594
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Infectious Diseases. Vol.196, No.11 (2007), 1707-1716
Suggested Citation
W. Joost Wiersinga, Cees Van 'T Veer, Catharina W. Wieland, Sebastien Gibot, Berend Hooibrink, Nicholas P. Day, Sharon J. Peacock, Tom Van Der Poll Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. Journal of Infectious Diseases. Vol.196, No.11 (2007), 1707-1716. doi:10.1086/522141 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/24665
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis
Abstract
Background. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies Toll-like receptor-initiated responses against pathogens. We aimed to characterize TREM-1 expression and function during sepsis caused by Burkholderia pseudomallei (melioidosis). Methods. TREM-1 expression was determined on leukocytes and plasma from 34 patients with melioidosis and 32 controls and in mice with experimentally induced melioidosis. Responsiveness toward B. pseudomallei of TREM-1+and TREM-1-leukocytes was tested in vitro. TREM-1 function was inhibited in mice by a synthetic peptide mimicking the ectodomain of this receptor. Results. Patients demonstrated increased soluble (s) TREM-1 plasma levels and TREM-1 surface expression on monocytes but not granulocytes. Similarly, mice inoculated with B. pseudomallei displayed a gradual rise in sTREM-1 level and an increase in blood monocyte but not granulocyte TREM-1 expression. At the primary infection site, however, granulocyte TREM-1 expression was enhanced, and the rise in sTREM-1 level occurred earlier. Additionally, purified human TREM-1-granulocytes showed reduced responsiveness to B. pseudomallei relative to TREM-1+granulocytes, a difference not detected for TREM-1+and TREM-1+monocytes. Treatment with a peptide mimicking a conserved domain of sTREM-1 partially protected mice from B. pseudomallei-induced lethality. Conclusions. During melioidosis, TREM-1 expression is differentially regulated on granulocytes and monocytes; measurement of TREM-1 expression on blood granulocytes may not provide adequate information on granulocyte TREM-1 expression at the infection site. TREM-1 may be a therapeutic target in melioidosis. © 2007 by the Infectious Diseases Society of America. All rights reserved.